与慢性肾脏病及低骨转换相关的钙过敏：重组人甲状旁腺激素（1-34）治疗 - Suppr

Suppr

超能文献

Calciphylaxis associated with chronic kidney disease and low bone turnover: management with recombinant human PTH-(1-34).

作者信息

Elder Grahame, Kumar Karthic S

机构信息

Department of Renal Medicine, Westmead Hospital, Australia.

出版信息

NDT Plus. 2008 Apr;1(2):97-99. doi: 10.1093/ndtplus/sfn008. Epub 2008 Feb 14.

DOI:10.1093/ndtplus/sfn008

PMID:28657007

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5477913/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc2d/5477913/bc5beb6873d1/sfn008fig1.jpg

相似文献

Calciphylaxis associated with chronic kidney disease and low bone turnover: management with recombinant human PTH-(1-34).与慢性肾脏病及低骨转换相关的钙过敏：重组人甲状旁腺激素（1-34）治疗

NDT Plus. 2008 Apr;1(2):97-99. doi: 10.1093/ndtplus/sfn008. Epub 2008 Feb 14.

Calcific uremic arteriolopathy in association with low turnover uremic bone disease.

Clin Nephrol. 1999 Sep;52(3):160-6.

[Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].3、4、5期慢性肾脏病（未透析）患者矿物质代谢的变化

Nefrologia. 2008;28 Suppl 3:67-78.

Calciphylaxis after parathyroidectomy.甲状旁腺切除术后的钙化防御。

Hemodial Int. 2017 Oct;21 Suppl 2:S62-S66. doi: 10.1111/hdi.12599.

Serum phosphorus adds to value of serum parathyroid hormone for assessment of bone turnover in renal osteodystrophy.血清磷增加了血清甲状旁腺激素在评估肾性骨营养不良骨转换中的价值。

Clin Nephrol. 2016 Jul;86(7):9-17. doi: 10.5414/CN108823.

A case report of severe calciphylaxis - suggested approach for diagnosis and treatment.一例严重钙化防御的病例报告——诊断与治疗的建议方法

BMC Nephrol. 2017 Apr 21;18(1):137. doi: 10.1186/s12882-017-0556-z.

Parathyroid hormone variability parameters for identifying high turnover osteodystrophy disease in hemodialysis patients: an observational retrospective cohort study.用于识别血液透析患者高转化性骨营养不良疾病的甲状旁腺激素变异性参数：一项观察性回顾性队列研究。

Ther Apher Dial. 2010 Dec;14(6):566-71. doi: 10.1111/j.1744-9987.2010.00822.x.

Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis.慢性维持性透析患者血清甲状旁腺激素水平对骨转换的预测价值。

Am J Kidney Dis. 1995 Oct;26(4):622-31. doi: 10.1016/0272-6386(95)90599-5.

Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study.骨转换标志物与骨密度相关，但与终末期肾病患者的骨折无关：一项横断面研究。

BMC Nephrol. 2017 Sep 6;18(1):284. doi: 10.1186/s12882-017-0692-5.

Hypoalbuminemia differently affects the serum bone turnover markers in hemodialysis patients.低白蛋白血症对血液透析患者的血清骨转换标志物有不同的影响。

Int J Med Sci. 2019 Oct 21;16(12):1583-1592. doi: 10.7150/ijms.39158. eCollection 2019.

引用本文的文献

Course and treatment of severe osteoporosis complicated by calciphylaxis: a case report.重度骨质疏松症合并钙化防御的病程及治疗：一例报告

JBMR Plus. 2024 Nov 22;9(1):ziae154. doi: 10.1093/jbmrpl/ziae154. eCollection 2025 Jan.

Is Adynamic Bone Always a Disease? Lessons from Patients with Chronic Kidney Disease.骨动力不足就一定是疾病吗？来自慢性肾病患者的经验教训。

J Clin Med. 2022 Nov 30;11(23):7130. doi: 10.3390/jcm11237130.

Study on the Prevalence of Vascular Calcification in Different Types of Arteries and Influencing Factors in Maintenance Peritoneal Dialysis Patients.维持性腹膜透析患者不同类型动脉血管钙化的患病率及影响因素研究。

Blood Purif. 2019;47 Suppl 1(Suppl 1):8-16. doi: 10.1159/000496218. Epub 2019 Jan 30.

本文引用的文献

Calciphylaxis: a rare complication of patients who required parathyroidectomy for advanced renal hyperparathyroidism.钙过敏症：晚期肾性甲状旁腺功能亢进症患者接受甲状旁腺切除术后的一种罕见并发症。

World J Surg. 2005 May;29(5):632-5. doi: 10.1007/s00268-005-7514-9.

Teriparatide (human parathyroid hormone (1-34)) inhibits osteogenic vascular calcification in diabetic low density lipoprotein receptor-deficient mice.特立帕肽（人甲状旁腺激素（1-34））可抑制糖尿病低密度脂蛋白受体缺陷小鼠的成骨性血管钙化。

J Biol Chem. 2003 Dec 12;278(50):50195-202. doi: 10.1074/jbc.M308825200. Epub 2003 Sep 22.

On the role of adjuvants in calciphylaxis.

Q Rev Allergy Appl Immunol. 1961 Jul-Aug;15:461-5.

Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment.

Semin Dial. 2002 May-Jun;15(3):172-86. doi: 10.1046/j.1525-139x.2002.00052.x.

Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy.钙过敏通常无溃疡形成：危险因素、结局及治疗

Kidney Int. 2002 Jun;61(6):2210-7. doi: 10.1046/j.1523-1755.2002.00375.x.

Risk factors and mortality associated with calciphylaxis in end-stage renal disease.终末期肾病中与钙化防御相关的危险因素及死亡率

Kidney Int. 2001 Jul;60(1):324-32. doi: 10.1046/j.1523-1755.2001.00803.x.

Calciphylaxis in the absence of renal failure.

Clin Exp Dermatol. 2000 Jul;25(5):389-92. doi: 10.1046/j.1365-2230.2000.00671.x.

Calcific uremic arteriolopathy in association with low turnover uremic bone disease.

Clin Nephrol. 1999 Sep;52(3):160-6.

Calcium use increases risk of calciphylaxis: a case-control study.钙的使用增加了钙化防御的风险：一项病例对照研究。

Perit Dial Int. 1999 May-Jun;19(3):248-52.

Calciphylaxis: a syndrome of skin necrosis and acral gangrene in chronic renal failure.钙过敏：一种慢性肾衰竭患者出现皮肤坏死和肢端坏疽的综合征。

Vasa. 1998 Aug;27(3):137-43.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验